Comparison

CEF2, Influenza Virus PA (46-54) - 1 mg

Item no. AS-28311
Manufacturer AnaSpec
Amount 1 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Purity Peak Area by HPLC ≥95%
Sequence H-Phe-Met-Tyr-Ser-Asp-Phe-His-Phe-Ile-OH
Citations Ref: Gianfrani C. et al. Human Immunol. 61, 438 (2000); Macken, C. et al. "The value of a database in surveillance and vaccine selection." in Options for the Control of Influenza IV. A.D.M.E. Osterhaus, N. Cox & A.W. Hampson (Eds.) Amsterdam: Elsevier Science, 103 (2001). Berkhoff, E. et al. J. Virol. 78: 5216 (2004).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias FMYSDFHFI
Shipping Condition Room temperature
Available
Manufacturer - Type
Catalog
Manufacturer - Category
Peptides
Manufacturer - Targets
Influenza Virus
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
1206.4
Description
HLA-A*0201 restricted epitope from influenza virus RNA polymerase subunit, PA (46-54).
Product Group
LB1A1Z
Research Area
Immunology and Infectious disease / Lyophilized
Sequence One-Letter Code
FMYSDFHFI
GTIN
5400535023867
Usage
Research use
UNSPSC
12352202

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close